GAO Issues Report: Drug Development - Pathway for Approving Antibacterial and Antifungal Drugs for Patients With Limited Treatment Options Is Infrequently Used
CR - GAO Reports
Copyright © Targeted News Service, 2021
Copyright © Targeted News Service, 2021
2021-11-20
Targeted News Service
WASHINGTON, Nov. 20 -- The Government Accountability Office has issued a report (GAO-22-105042) entitled "Drug Development - Pathway for Approving Antibacterial and Antifungal Drugs for Patients with Limited Treatment Options is Infrequently Used".
The report was sent to Sen. Patty Murray, D-Washington, chairman, Sen. Richard Burr, R-North Carolina, ranking member of the Senate Health, Education, Labor & Pensions Committee, Rep. Frank Pallone Jr., D-New Jersey, chairman, and Rep. Ca . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Nov. 20 -- The Government Accountability Office has issued a report (GAO-22-105042) entitled "Drug Development - Pathway for Approving Antibacterial and Antifungal Drugs for Patients with Limited Treatment Options is Infrequently Used".
The report was sent to Sen. Patty Murray, D-Washington, chairman, Sen. Richard Burr, R-North Carolina, ranking member of the Senate Health, Education, Labor & Pensions Committee, Rep. Frank Pallone Jr., D-New Jersey, chairman, and Rep. Ca . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com